19 states and D.C. sue HHS to block Kennedy plan cutting Medicare/Medicaid for youth trans care
A coalition of 19 states and the District of Columbia sued HHS Tuesday in U.S. District Court in Eugene, Oregon, challenging Secretary Robert F. Kennedy Jr.’s declaration that puberty blockers, cross‑sex hormones and transition‑related surgeries for minors are unsafe and warning providers they could be excluded from Medicare and Medicaid; plaintiffs led by New York AG Letitia James and including Pennsylvania Gov. Josh Shapiro say the declaration is inaccurate, unlawful and was issued without required notice‑and‑comment rulemaking. The suit does not yet directly contest two separate HHS proposed rules that would bar Medicaid/CHIP payments and threaten hospitals’ Medicare/Medicaid participation, but critics — including major medical groups — say the broader federal actions, along with related OCR and FDA moves, would sharply curtail youth access to gender‑affirming care.
📌 Key Facts
- HHS and CMS unveiled a package of proposed regulatory actions that would treat providing puberty blockers, cross‑sex hormones and certain surgeries to patients under 18 as violations of Medicare/Medicaid hospital conditions of participation and would bar federal Medicaid funding for gender‑transition procedures for those under 18 (with CHIP restrictions for those under 19).
- HHS says its actions are grounded in a November peer‑reviewed internal report that found 'significant, long term' risks, criticized WPATH standards, urged greater reliance on behavioral therapy, and concluded many transition‑related treatments for minors do not meet professional medical standards—finding that prompted HHS Secretary Robert F. Kennedy Jr. to sign a declaration condemning such care as unsafe and ineffective.
- The department is also proposing to revise Section 504 regulations to explicitly exclude gender dysphoria not caused by a physical impairment from the definition of 'disability,' and the FDA sent warning letters to multiple companies (including GenderBender LLC and TomboyX) over marketing chest/breast binders to children.
- HHS and supporters frame the moves as a nationwide funding cutoff that could effectively ban most hospital‑based gender‑affirming care for minors because nearly all U.S. hospitals participate in Medicare and Medicaid (roughly 45% of hospital revenue comes from those programs), prompting many hospitals to curtail or stop such care in anticipation of federal action.
- Major medical and child‑health organizations—including the American Academy of Pediatrics, the American Medical Association (noted in reporting), and the American Psychological Association—have criticized the federal actions, saying they misconstrue medical consensus and risk patients' health; the Children's Hospital Association warned the approach would set a dangerous precedent for withholding specialized care.
- At the HHS announcement, Secretary Kennedy invoked 'gold standard science' and tied the proposals to President Trump's January executive order banning federal support for youth gender‑affirming care; detransitioner Chloe Cole spoke at the event describing personal complications (puberty blockers, testosterone, double mastectomy between ages 12–16) and has a pending lawsuit over her care.
- A coalition of 19 Democratic‑led states plus the District of Columbia filed suit in U.S. District Court in Eugene, Oregon, challenging Kennedy's online declaration as inaccurate, unlawful and issued without required notice‑and‑comment rulemaking; the complaint says the declaration unlawfully coerces providers to stop gender‑affirming care for minors. (The suit does not yet directly challenge the two formal proposed rules because they are not final.)
- The hospital‑funding rule carries a 60‑day public comment period before it could be finalized; civil‑rights groups such as the ACLU are preparing legal challenges and observers say a lengthy rulemaking and litigation process is likely.
📊 Relevant Data
Among U.S. youth aged 13 to 17, 3.3% identify as transgender, comprising about 724,000 youth.
How Many Adults and Youth Identify as Transgender in the United States? — Williams Institute
Transgender identification among U.S. young adults aged 18-25 declined from 7.8% in 2020 to 3.7% in 2024.
The Sharp Decline in Transgender Identification Among Young Adults — Graphs About Religion
Youth and young adults are more likely to identify as transgender due to a variety of factors, including a greater willingness among younger generations to express their gender identity and increased societal acceptance of diverse gender identities.
New estimate: 2.8 million people aged 13 and older identify as transgender in the U.S. — Williams Institute
Latinx people, American Indian or Alaska Native people, and biracial/multiracial groups appear more likely than White people to identify as transgender.
How Many Adults and Youth Identify as Transgender in the United States? — Williams Institute
Transgender identification among young adults increased 464% in blue states and 378% in red states between 2014 and 2023.
Transgender identity: How much has it increased? — Generation Tech
📊 Analysis & Commentary (1)
How natural are “arbitrary” sex differences?
"A critical opinion piece that interrogates claims calling sex differences 'arbitrary,' arguing that such rhetoric oversimplifies biology and society and is being (or could be) used to justify restrictive policies on youth gender care, calling instead for careful, evidence‑based, ethically grounded policymaking."
📰 Sources (11)
19 states sue to block Kennedy's plan to curb trans care
New information:
- Axios specifies that the policy would stop Medicare and Medicaid payments to any provider offering gender-affirming care to minors, framing it as a funding cutoff rather than just a warning of possible exclusion.
- The piece lists the full political lineup of plaintiffs, noting Pennsylvania Gov. Josh Shapiro personally joined alongside Democratic attorneys general from 18 other states and D.C.
- HHS ties the proposed funding ban directly to President Trump’s January executive order banning federal funding and support for youth gender-affirming care and reiterates Kennedy’s quote about doing 'everything in its power' to stop what he calls 'unsafe, irreversible practices.'
- Axios explicitly notes that major U.S. medical organizations (AMA, American Academy of Pediatrics) consider gender-affirming care medically necessary and potentially lifesaving for transgender youth, underscoring the medical community’s stance in the dispute.
Nearly 20 states sue HHS over declaration to restrict gender transition treatment for minors
New information:
- Fox article emphasizes that all 19 plaintiff states plus D.C. are Democrat-led, framing it explicitly as a partisan coalition.
- Restates that the lawsuit directly targets the HHS declaration that labels puberty blockers, hormones and surgeries for minors as unsafe and warns providers they could be excluded from Medicare and Medicaid if they offer such care.
- Highlights HHS Secretary Robert F. Kennedy Jr.’s quote that the department is taking 'six decisive actions guided by gold standard science' and explicitly ties the declaration to Trump’s January executive order to protect children from 'chemical and surgical mutilation.'
- Reiterates that plaintiffs argue the declaration attempts to pressure providers to halt youth gender transition care and violates federal notice-and-comment requirements for substantive policy changes.
- Notes again that HHS has separately proposed two formal rules to cut off Medicaid/Medicare funding for hospitals providing youth gender transition care and to block federal Medicaid funding for such procedures, though those rules are not directly challenged in the suit.
19 states sue HHS over a move that could curtail youth gender-affirming care
New information:
- Confirms the lawsuit was filed Tuesday in U.S. District Court in Eugene, Oregon.
- Details the plaintiffs’ core legal arguments that the HHS declaration is inaccurate, unlawful, and violates federal notice-and-comment requirements.
- Describes the declaration’s warning that doctors could be excluded from Medicare and Medicaid if they provide youth gender-affirming care.
- Notes that the declaration is based on a peer-reviewed internal HHS report urging more reliance on behavioral therapy and questioning WPATH standards and minors’ ability to consent.
- Includes on-the-record criticism from New York Attorney General Letitia James and notes that a spokesperson for HHS declined to comment.
- Clarifies that the new lawsuit does not yet directly challenge HHS’s two newly proposed rules to cut off Medicaid/Medicare funding for hospitals providing youth gender-affirming care, because they are not final.
19 states and D.C. sue HHS over effort to ban transgender care for minors
New information:
- A coalition of 19 states plus the District of Columbia filed a lawsuit Tuesday in U.S. District Court in Eugene, Oregon against HHS, Secretary Robert F. Kennedy Jr., and the HHS inspector general.
- The suit specifically challenges last Thursday’s HHS declaration that labeled puberty blockers, hormone therapy and surgeries for minors as unsafe and ineffective and warned providers they could be excluded from Medicare and Medicaid for offering such care.
- Plaintiffs argue the declaration is inaccurate, unlawful and issued without required notice-and-comment procedures, and allege it unlawfully coerces providers to stop gender-affirming treatment for minors.
- The article details that HHS’s declaration relies on a peer‑reviewed internal report advocating greater use of behavioral therapy over broad gender‑affirming care for youth and critiquing WPATH standards, including concerns over minor consent and potential infertility.
- New York Attorney General Letitia James is leading the coalition and is quoted criticizing the secretary’s ability to 'unilaterally change medical standards' via an online document.
- The piece clarifies that the two newly unveiled HHS proposed rules on cutting Medicare/Medicaid funding for youth gender care are not yet final, are not directly challenged in this lawsuit, but are part of a broader Trump administration campaign to limit transgender care for minors.
Trump's push to end transgender care for young people opposed by pediatricians
New information:
- The American Academy of Pediatrics (AAP) president Dr. Susan J. Kressly issued a statement saying the new federal policies "misconstrue the current medical consensus" and "unfairly stigmatize" transgender youth, stressing that the AAP’s official position is that gender‑affirming care is safe and effective for the young people who need it.
- The American Psychological Association released a statement saying it is "deeply concerned" that recent federal actions challenge the scientific understanding of gender identity and may jeopardize the human rights and psychological health of transgender and nonbinary individuals.
- Children's Hospital Association CEO Matthew Cook warned that conditioning Medicare and Medicaid participation on ending gender‑affirming care for minors would set a "dangerous precedent" that could allow the government to withhold many types of specialized care, potentially causing millions of families to lose access to needed treatment.
- The article quotes Acting CDC Director Jim O'Neill saying "Men are men. Men can never become women. Women are women. Women can never become men" and calling the "blurring of the lines between sexes" a "hatred for nature as God designed it," underscoring the ideological framing used by federal health officials.
- HHS Secretary Robert F. Kennedy Jr. is quoted accusing doctors and medical groups of having "peddled the lie" that gender‑affirming treatments are good for children and asserting that youth are "conditioned to believe that sex can be changed."
- The article notes that the administration is explicitly basing its actions on a November HHS report that concluded clinicians providing transition‑related care to youth have failed their patients and emphasized psychotherapy as an alternative.
- State attorneys general in New York and California are quoted as pledging to fight the rules and protect access to transgender health care in their states.
- The article reiterates that there is a 60‑day public comment period after which the hospital funding rule could be finalized and take effect, clarifying near‑term timing.
Trump administration moves to restrict gender affirming care for minors nationwide
New information:
- PBS segment specifies that roughly 45% of hospital spending comes from Medicare and Medicaid, underscoring the potentially 'existential' financial threat to hospitals if they continue providing gender‑affirming care for minors.
- Clarifies that children’s hospitals have been key providers of gender‑affirming care, often using interdisciplinary teams including therapists and psychiatrists, and that such care would likely cease in hospitals nationwide if the rules take effect.
- Explains that HHS is using 'conditions of participation'—usually reserved for basic health and safety requirements like crash carts and staffing ratios—to enforce the policy, highlighting how unprecedented this mechanism is for restricting a specific category of medical care.
- Includes on‑camera, direct remarks by HHS Secretary Robert F. Kennedy Jr. describing transition‑related procedures as 'sex‑rejecting' and asserting they are 'neither safe nor effective' and not professionally recognized standards of care.
- Notes that, although these are proposed rules, major civil‑rights organizations such as the ACLU are already preparing to sue and that a 'lengthy rulemaking process' must occur before they can be enforced.
Detransitioner Chloe Cole shares complications after gender procedures: 'I am grieving'
New information:
- Identifies detransitioner Chloe Cole as a central figure at the HHS announcement event, speaking alongside HHS Secretary Robert F. Kennedy Jr.
- Details Cole’s specific medical history: puberty blockers, testosterone injections and a double mastectomy between ages 12 and 16.
- Describes concrete long‑term complications she reports, including unknown fertility, inability to breastfeed, failing areolar skin grafts requiring daily bandages and lack of follow‑up care from original providers.
- Quotes Cole’s account that her parents were warned she would likely commit suicide if they did not consent to transition, which she characterizes as a decision made under duress.
- Notes that Cole has filed a lawsuit (filed in 2023) over her care, providing additional legal context to the regulatory push.
Trump administration unveils proposals to cut off transgender care for minors
New information:
- CBS specifies that the package is a 'series of regulatory actions' that together are designed to effectively ban gender-affirming care for minors by threatening hospitals’ participation in Medicare and Medicaid.
- Clarifies that the same funding restrictions will also apply to the State Children’s Health Insurance Program (CHIP) for people under 19, as described in a federal notice posted Thursday morning.
- Provides fresh on-camera quotes from HHS Secretary Robert F. Kennedy Jr. calling pediatric gender-affirming procedures 'not medicine' but 'malpractice' that 'rob children of their futures.'
- Quantifies current state policy landscape: Medicaid in 'slightly less than half' of states covers gender-affirming care, while at least 27 states have adopted laws restricting or banning such care, in the wake of the Supreme Court’s ruling upholding Tennessee’s SB1.
- Details that many hospitals have already ceased providing gender-affirming care for minors in anticipation of these federal actions and that the proposals, though not yet binding, are expected to further chill providers.
- Names specific companies receiving FDA warning letters over chest binders and related products, including GenderBender LLC of Carson, California, and TomboyX of Seattle, and explains that FDA says binders can only be legally marketed for approved medical indications such as post‑mastectomy recovery.
- Quotes reaction from Rodrigo Heng‑Lehtinen of The Trevor Project, calling the moves a 'one-size-fits-all mandate from the federal government' and warning they will put lives at risk.
WATCH: Trump administration seeks to cut off access to transgender health care for U.S. children
New information:
- Clarifies that the proposals are the 'most significant' Trump‑era moves so far to restrict puberty blockers, hormone therapy and surgeries for minors, and are designed to 'effectively ban' gender‑affirming care for children nationwide.
- Specifies that nearly all U.S. hospitals participate in Medicare and Medicaid and that losing access to those payments would 'imperil most U.S. hospitals and medical providers,' underscoring the leverage of the funding cutoff.
- Notes that the same federal funding restrictions would also apply to the State Children’s Health Insurance Program (CHIP) for those under 19, according to a federal notice posted Thursday.
- Adds more detail on the HHS Office for Civil Rights plan to propose a rule explicitly excluding gender dysphoria from the definition of a disability.
- Identifies additional FDA warning letters beyond prior reporting, including to companies such as GenderBender LLC (Carson, California) and TomboyX (Seattle), and states that chest binders can only be legally marketed for FDA‑approved uses like post‑mastectomy recovery.
- Reports that many hospitals have already ceased gender‑affirming care for minors in anticipation of federal action, and that the proposed rules are likely to further intimidate providers even before finalization.
- Reiterates that more than half of U.S. states have already banned or restricted gender‑affirming care, but these federal actions would newly imperil access in nearly two dozen states where such care remains legal and Medicaid‑funded.
HHS unleashes sweeping crackdown on child ‘sex-rejecting procedures,’ threatens hospital, Medicaid funding (e
New information:
- HHS and CMS are rolling out specific proposed regulatory actions that would make providing puberty blockers, cross-sex hormones and certain surgeries to patients under 18 a violation of Medicare and Medicaid hospital conditions of participation.
- A separate CMS proposed rule would bar federal Medicaid funding for gender-transition procedures for individuals under 18, and extend the same restriction to CHIP funding for those under 19.
- HHS cites a November peer‑reviewed report from the Office of the Assistant Secretary for Health concluding that puberty blockers, cross‑sex hormones and surgical procedures on minors carry 'significant, long term' risks and are often poorly tracked.
- Based on that report, HHS Secretary Robert F. Kennedy Jr. signed a declaration stating that gender-transition procedures for minors do not meet professional medical standards, and that practitioners performing them would be deemed out of compliance.
- HHS is proposing to revise Section 504 regulations so that 'gender dysphoria' not caused by a physical impairment is explicitly excluded from the definitions of 'disability' and 'individual with a disability.'
- The FDA sent warning letters to 12 manufacturers and retailers over the 'illegal marketing of breast binders to children' as part of the same policy crackdown.